290 related articles for article (PubMed ID: 20177148)
21. Vascular endothelial growth factor stimulates endothelial differentiation from mesenchymal stem cells via Rho/myocardin-related transcription factor--a signaling pathway.
Wang N; Zhang R; Wang SJ; Zhang CL; Mao LB; Zhuang CY; Tang YY; Luo XG; Zhou H; Zhang TC
Int J Biochem Cell Biol; 2013 Jul; 45(7):1447-56. PubMed ID: 23624342
[TBL] [Abstract][Full Text] [Related]
22. Oncostatin M stimulates expression of stromal-derived factor-1 in human mesenchymal stem cells.
Lee MJ; Song HY; Kim MR; Sung SM; Jung JS; Kim JH
Int J Biochem Cell Biol; 2007; 39(3):650-9. PubMed ID: 17169599
[TBL] [Abstract][Full Text] [Related]
23. The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration.
Bian D; Mahanivong C; Yu J; Frisch SM; Pan ZK; Ye RD; Huang S
Oncogene; 2006 Apr; 25(15):2234-44. PubMed ID: 16301993
[TBL] [Abstract][Full Text] [Related]
24. Macrophages regulate smooth muscle differentiation of mesenchymal stem cells via a prostaglandin F₂α-mediated paracrine mechanism.
Lee MJ; Kim MY; Heo SC; Kwon YW; Kim YM; Do EK; Park JH; Lee JS; Han J; Kim JH
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2733-40. PubMed ID: 22962328
[TBL] [Abstract][Full Text] [Related]
25. Simvastatin inhibits sphingosylphosphorylcholine-induced differentiation of human mesenchymal stem cells into smooth muscle cells.
Kim KH; Kim YM; Lee MJ; Ko HC; Kim MB; Kim JH
Exp Mol Med; 2012 Feb; 44(2):159-66. PubMed ID: 22127053
[TBL] [Abstract][Full Text] [Related]
26. LPA-induced epithelial ovarian cancer (EOC) in vitro invasion and migration are mediated by VEGF receptor-2 (VEGF-R2).
So J; Wang FQ; Navari J; Schreher J; Fishman DA
Gynecol Oncol; 2005 Jun; 97(3):870-8. PubMed ID: 15919106
[TBL] [Abstract][Full Text] [Related]
27. Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism.
Seo EJ; Kwon YW; Jang IH; Kim DK; Lee SI; Choi EJ; Kim KH; Suh DS; Lee JH; Choi KU; Lee JW; Mok HJ; Kim KP; Matsumoto H; Aoki J; Kim JH
Stem Cells; 2016 Mar; 34(3):551-64. PubMed ID: 26800320
[TBL] [Abstract][Full Text] [Related]
28. Lysophosphatidic acid receptor 2 and Gi/Src pathway mediate cell motility through cyclooxygenase 2 expression in CAOV-3 ovarian cancer cells.
Jeong KJ; Park SY; Seo JH; Lee KB; Choi WS; Han JW; Kang JK; Park CG; Kim YK; Lee HY
Exp Mol Med; 2008 Dec; 40(6):607-16. PubMed ID: 19116446
[TBL] [Abstract][Full Text] [Related]
29. The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion.
Jeong KJ; Park SY; Cho KH; Sohn JS; Lee J; Kim YK; Kang J; Park CG; Han JW; Lee HY
Oncogene; 2012 Sep; 31(39):4279-89. PubMed ID: 22249252
[TBL] [Abstract][Full Text] [Related]
30. Angiogenic capacity of human adipose-derived stromal cells during adipogenic differentiation: an in vitro study.
Verseijden F; Jahr H; Posthumus-van Sluijs SJ; Ten Hagen TL; Hovius SE; Seynhaeve AL; van Neck JW; van Osch GJ; Hofer SO
Tissue Eng Part A; 2009 Feb; 15(2):445-52. PubMed ID: 18652540
[TBL] [Abstract][Full Text] [Related]
31. Lysophosphatidic acid induces focal adhesion assembly through Rho/Rho-associated kinase pathway in human ovarian cancer cells.
Sawada K; Morishige Ki; Tahara M; Ikebuchi Y; Kawagishi R; Tasaka K; Murata Y
Gynecol Oncol; 2002 Dec; 87(3):252-9. PubMed ID: 12468322
[TBL] [Abstract][Full Text] [Related]
32. Proteomic identification of ADAM12 as a regulator for TGF-β1-induced differentiation of human mesenchymal stem cells to smooth muscle cells.
Kim YM; Kim J; Heo SC; Shin SH; Do EK; Suh DS; Kim KH; Yoon MS; Lee TG; Kim JH
PLoS One; 2012; 7(7):e40820. PubMed ID: 22808268
[TBL] [Abstract][Full Text] [Related]
33. Lysophosphatidic acid stimulates cell growth by different mechanisms in SKOV-3 and Caov-3 ovarian cancer cells: distinct roles for Gi- and Rho-dependent pathways.
Hurst JH; Hooks SB
Pharmacology; 2009; 83(6):333-47. PubMed ID: 19420982
[TBL] [Abstract][Full Text] [Related]
34. LPA-induced migration of ovarian cancer cells requires activation of ERM proteins via LPA
Park J; Jang JH; Oh S; Kim M; Shin C; Jeong M; Heo K; Park JB; Kim SR; Oh YS
Cell Signal; 2018 Apr; 44():138-147. PubMed ID: 29329782
[TBL] [Abstract][Full Text] [Related]
35. Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancer.
Lee Z; Swaby RF; Liang Y; Yu S; Liu S; Lu KH; Bast RC; Mills GB; Fang X
Cancer Res; 2006 Mar; 66(5):2740-8. PubMed ID: 16510595
[TBL] [Abstract][Full Text] [Related]
36. Lysophosphatidic acid protects human mesenchymal stromal cells from differentiation-dependent vulnerability to apoptosis.
Binder BY; Genetos DC; Leach JK
Tissue Eng Part A; 2014 Apr; 20(7-8):1156-64. PubMed ID: 24131310
[TBL] [Abstract][Full Text] [Related]
37. Sp-1 and c-Myc mediate lysophosphatidic acid-induced expression of vascular endothelial growth factor in ovarian cancer cells via a hypoxia-inducible factor-1-independent mechanism.
Song Y; Wu J; Oyesanya RA; Lee Z; Mukherjee A; Fang X
Clin Cancer Res; 2009 Jan; 15(2):492-501. PubMed ID: 19147754
[TBL] [Abstract][Full Text] [Related]
38. Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro.
Guiducci S; Manetti M; Romano E; Mazzanti B; Ceccarelli C; Dal Pozzo S; Milia AF; Bellando-Randone S; Fiori G; Conforti ML; Saccardi R; Ibba-Manneschi L; Matucci-Cerinic M
Ann Rheum Dis; 2011 Nov; 70(11):2011-21. PubMed ID: 21821866
[TBL] [Abstract][Full Text] [Related]
39. Sphingosylphosphorylcholine induces proliferation of human adipose tissue-derived mesenchymal stem cells via activation of JNK.
Jeon ES; Song HY; Kim MR; Moon HJ; Bae YC; Jung JS; Kim JH
J Lipid Res; 2006 Mar; 47(3):653-64. PubMed ID: 16339111
[TBL] [Abstract][Full Text] [Related]
40. VEGFR-2 silencing by small interference RNA (siRNA) suppresses LPA-induced epithelial ovarian cancer (EOC) invasion.
Wang FQ; Barfield E; Dutta S; Pua T; Fishman DA
Gynecol Oncol; 2009 Dec; 115(3):414-23. PubMed ID: 19765808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
